Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response
News provided by
Share this article
Share this article
CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ Celdara Medical, LLC ( Celdara ) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses. This project builds on the discoveries of Principal Investigator Jason Botten, a professor at the University of Vermont s Larner College of Medicine in Burlington, Vt. Dr. Botten is also scientific founder of Celdara, and a founding member of Celdara s Pandemic Security Initiative Scientific Advisory Board.
National Medical Association President Dr. Leon McDougle (Courtesy photo)
Vermont Business Magazine Consistent with a history that is rife with medical discrimination and abuse against Black people, the COVID-19 pandemic has disproportionately affected BIPOC communities in the U.S., who are disproportionally employed as essential workers. Now, as vaccines are distributed to specific populations in phases, concerns are rising that this health disparity gap may widen. On Wednesday, January 20, Leon McDougle, MD, MPH, president of the National Medical Association, will address health care inequities as the Keynote Speaker for the University of Vermont s annual Rev. Dr. Martin Luther King Jr. Celebration.
ISU alumnus Jacobson named CEO of V Foundation for Cancer Research Wednesday, January 6, 2021 3:35 PM The V Foundation for Cancer Research, a top-rated cancer research charity, has named Shane Jacobson as its new chief executive officer. Jacobson, an Iowa State University alumnus and former vice president for development and alumni relations at Grinnell College, succeeds foundation CEO Susan Braun upon her retirement. Jacobson, most recently president and CEO of the University of Vermont Foundation, brings with him two decades of fundraising experience. “Combining his passion for sports and eradicating cancer, this new role will allow Jacobson to build upon the V Foundation’s tremendous growth over the past decade,” the organization said in a press release. Jacobson received his bachelor’s and master’s degrees from Iowa State University, and completed the Harvard University Management Development Program. At the University of Vermont, he le
Related Company:
AI software uses routine blood work to assist clinical labs with COVID testing shortage
Vermont Business Magazine Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv’s new AI-COVID software. The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the
“Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19,” says lead author and University of Vermont Assistant Professor Timothy Plante, MD, “but there’s still a big bottleneck in COVID-19 diagnosis with PCR testing.”
Time to speak up samessenger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from samessenger.com Daily Mail and Mail on Sunday newspapers.